Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Apellis Pharmaceuticals, Inc. | 68,299 | reported | 01 Dec 2023 | tx 55+565,980−139,588 |
| ACUCELA INC. | 66,587 | reported | 17 Jul 2017 | tx 40+317,098−103,421 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Dec 2023 | SALE | Apellis Pharmaceuticals, Inc. | 10,000 | 60.00 USD | |
| 01 Dec 2023 | EXERCISE | Apellis Pharmaceuticals, Inc. | 10,000 | 13.85 USD | |
| 01 Dec 2023 | EXERCISE | Apellis Pharmaceuticals, Inc. | 10,000 | 0.00 USD | deriv |
| 06 Sept 2023 | SALE | Apellis Pharmaceuticals, Inc. | 1,756 | 43.01 USD | |
| 21 Feb 2023 | TAX_WITHHOLDING | Apellis Pharmaceuticals, Inc. | 715 | 58.50 USD | |
| 21 Feb 2023 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 9,886 | 0.00 USD | |
| 21 Feb 2023 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 14,023 | 0.00 USD | deriv |
| 10 Feb 2023 | TAX_WITHHOLDING | Apellis Pharmaceuticals, Inc. | 678 | 51.21 USD | |
| 27 Jan 2023 | TAX_WITHHOLDING | Apellis Pharmaceuticals, Inc. | 542 | 52.77 USD | |
| 20 Jan 2023 | TAX_WITHHOLDING | Apellis Pharmaceuticals, Inc. | 2,015 | 52.05 USD | |
| 12 Jan 2023 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 22,580 | 0.00 USD | |
| 12 Jan 2023 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 35,472 | 52.66 USD | deriv |
| 27 May 2022 | SALE | Apellis Pharmaceuticals, Inc. | 10,000 | 43.00 USD | |
| 21 Apr 2022 | OTHER | Apellis Pharmaceuticals, Inc. | 1,875 | 0.00 USD | |
| 21 Apr 2022 | OTHER | Apellis Pharmaceuticals, Inc. | 11,250 | 0.00 USD | deriv |
| 05 Apr 2022 | EXERCISE | Apellis Pharmaceuticals, Inc. | 609 | 13.85 USD | |
| 05 Apr 2022 | SALE | Apellis Pharmaceuticals, Inc. | 609 | 60.09 USD | |
| 05 Apr 2022 | EXERCISE | Apellis Pharmaceuticals, Inc. | 609 | 0.00 USD | deriv |
| 04 Apr 2022 | SALE | Apellis Pharmaceuticals, Inc. | 1,249 | 57.81 USD | |
| 04 Apr 2022 | SALE | Apellis Pharmaceuticals, Inc. | 1,437 | 56.86 USD | |
| 04 Apr 2022 | SALE | Apellis Pharmaceuticals, Inc. | 818 | 55.84 USD | |
| 04 Apr 2022 | EXERCISE | Apellis Pharmaceuticals, Inc. | 3,504 | 13.85 USD | |
| 04 Apr 2022 | EXERCISE | Apellis Pharmaceuticals, Inc. | 3,504 | 0.00 USD | deriv |
| 01 Apr 2022 | SALE | Apellis Pharmaceuticals, Inc. | 11,496 | 55.05 USD | |
| 01 Apr 2022 | EXERCISE | Apellis Pharmaceuticals, Inc. | 11,496 | 13.85 USD |